Betsy Read-Connole Ph.D., DIvision of Cancer Biology, National Cancer Institute, NIH

Nneka N. Ufere, MD MSCE is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastroenterology at Massachusetts General Hospital and Harvard Medical School in Boston, MA. She is a health services and patient-centered outcomes researcher whose work is at the intersection of hepatology, transplant, and palliative care. As a clinical trialist, she develops and tests supportive care interventions aimed at increasing the quality of life, quality of care, and healthcare system empathy for patients with cirrhosis and their families.

Anji Wall is an abdominal transplant surgeon and bioethicist at the Baylor Simmons Transplant Institute in Dallas, TX, where she also serves as the vice chair of research and the medical director of the Baylor Scott and White Transplant Center for Innovation, Science, Policy Research and Ethics (INSPIRE). Her research interests include transplant policy ethics, innovative strategies to expand deceased organ donation, and the ethical challenges with deceased organ donation.

Dr. Ibrahim is a Professor of Pediatrics and Physiology; she is a pediatric transplant hepatologist and a physician scientist. Samar is the Principal Investigator of the NIH-funded lipotoxicity and liver inflammation laboratory at Mayo Clinic. She studies mechanisms of liver injury and inflammation in metabolic dysfunction associated steatohepatitis (MASH) with the goal to identify novel biomarkers and mechanism-based therapeutic targets.

Dr. Emily R. Perito is a Professor of Clinical Pediatrics at UCSF in the Departments of Pediatrics and of Epidemiology and Biostatistics. She is Medical Director of UCSF's multi-disciplinary Pediatric Liver Center. She is Co-Chair of the Starzl Network for Excellence in Pediatric Transplantation and helps lead their efforts to improve the efficacy and reduce the burden of immunosuppression for children after liver transplant.

Saul J. Karpen, M.D., Ph.D., FAASLD, is the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. He holds the Phillip B. Hylemon Endowed Chair of Medicine and Microbiology and is a pediatric hepatologist at the VCU Children's Hospital of Richmond.

Dr. Andrew Keaveny is a Professor of Medicine at the Mayo Clinic College of Medicine and Staff and Consultant Hepatologist at Mayo Clinic in Jacksonville, Florida. He graduated from the medical school at University College Dublin and pursued post-graduate training in Ireland and Boston, Massachusetts. His research interests include treatment of portal hypertension and improving outcomes after liver transplantation. He is a Fellow of the Royal College of Physicians in Ireland and the AASLD. Throughout his career, he has been very active in post-graduate education.

Lance L Stein MD is the Medical Director of Hepatology and Transplant at Piedmont Atlanta Hospital. Clinical Asst Prof of Medicine at Mercer University School of Medicine

MD